# Juanbi Pill for Rheumatoid Arthritis

> **NCT02885597** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Cui xuejun** · enrollment: 120 (estimated)

## Conditions studied

- Juanbi Pill
- Rheumatoid Arthritis

## Interventions

- **DRUG:** Juanbi pill
- **DRUG:** Juanbi pill placebo
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02885597
- **Lead sponsor:** Cui xuejun
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07
- **Primary completion:** 2018-12
- **Final completion:** 2020-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02885597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02885597, "Juanbi Pill for Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02885597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*